AAIC 2026: Lifestyle Factors and Prevention

Conference: [AAIC 2026](/events/aaic-2026) | Dates: July 12-15, 2026 | Location: Excel London, UK

Overview

AAIC 2026 features extensive research on lifestyle factors and modifiable risk factors for [Alzheimer's disease](/diseases/alzheimers-disease) prevention. This research builds on the 2024 Lancet Commission report identifying 14 modifiable risk factors that account for approximately 45% of dementia cases worldwide["@lifestyle2024"].

Lifestyle Modification and Dementia Risk

The 14 Modifiable Risk Factors

Conference: [AAIC 2026](/events/aaic-2026) | Dates: July 12-15, 2026 | Location: Excel London, UK

Overview

AAIC 2026 features extensive research on lifestyle factors and modifiable risk factors for [Alzheimer's disease](/diseases/alzheimers-disease) prevention. This research builds on the 2024 Lancet Commission report identifying 14 modifiable risk factors that account for approximately 45% of dementia cases worldwide["@lifestyle2024"].

Lifestyle Modification and Dementia Risk

The 14 Modifiable Risk Factors

The 2024 Lancet Commission update identified 14 modifiable risk factors across the life course[@lifestyle2024]:

| Life Stage | Risk Factors |
|------------|-------------|
| Early Life (<45 years) | Less education, Hearing loss |
| Midlife (45-65 years) | High LDL cholesterol, Traumatic brain injury, Hypertension, Excessive alcohol, Obesity, Physical inactivity |
| Later Life (>65 years) | Smoking, Depression, Social isolation, Air pollution, Diabetes, Vision loss |

See full details at: [Modifiable Risk Factors for Dementia](/mechanisms/modifiable-risk-factors)

Multi-Domain Intervention Trials

FINGER Trial (Finnish Geriatric Intervention Study)

The landmark FINGER trial demonstrated that a 2-year multidomain intervention (diet, exercise, cognitive training, vascular risk monitoring) improved cognitive performance by 25% relative to controls in at-risk older adults[@finger2024].

Key Findings from AAIC 2026:

• 10-year follow-up data showing sustained cognitive benefits
• Biomarker analysis demonstrating reduced amyloid and tau burden
• Successful adaptation to diverse populations through World-Wide FINGERS network[@worldfingers2024]

SPRINT-MIND Trial

The SPRINT-MIND trial evaluated intensive blood pressure control (target systolic <120 mmHg) versus standard control (target systolic <140 mmHg)[@sprint2024].

Key Findings:

• 19% reduction in risk of mild cognitive impairment
• Reduced white matter lesion progression
• Cardiovascular benefits maintained in hypertensive adults

• Vascular risk factors are major contributors to AD pathogenesis
• Blood pressure management in midlife is critical
• Integration with other lifestyle interventions maximizes benefit

PERSUADED Trial

The PERSUADED (Polyunsaturated Fatty Acid Supplementation) trial examined whether omega-3 fatty acid supplementation can slow cognitive decline in older adults at risk for AD[@persauded2024].

Key Findings from AAIC 2026:

• Subgroup analysis showing benefit in individuals with low baseline omega-3 levels
• Interaction with [APOE4](/genes/apoe) genotype
• Potential synergy with other lifestyle interventions

Dietary Patterns and Neuroprotection

Mediterranean Diet

The Mediterranean diet emphasizes:

• High consumption of vegetables, fruits, legumes, and whole grains
• Olive oil as primary fat source
• Moderate fish and poultry consumption
• Limited red meat and processed foods

• Correlation with reduced amyloid burden on PET imaging
• Association with slower cognitive decline
• Beneficial effects on gut microbiome composition

MIND Diet

The MIND (Mediterranean-DASH Intervention for Neurodegenerative Delay) diet combines elements of Mediterranean and DASH diets with a focus on brain-healthy foods:

• Green leafy vegetables (≥6 servings/week)
• Berries (≥2 servings/week)
• Nuts (≥5 servings/week)
• Whole grains (≥3 servings/day)
• Fish (≥1 serving/week)

• 35% reduction in AD risk with high adherence
• Synergistic effects when combined with physical activity

Ketogenic Approaches

Emerging research on ketogenic interventions:

• Ketone bodies as alternative energy substrate
• Potential benefits in individuals with insulin resistance
• Clinical trials ongoing in early AD

Physical Activity and Exercise

Aerobic Exercise

AAIC 2026 featured significant research on aerobic exercise benefits:

• Improved cerebral blood flow and cerebrovascular health
• Enhanced [BDNF](/entities/bdnf) expression and neurogenesis
• Reduced neuroinflammation and oxidative stress
• Dose-response relationship with cognitive benefits

Resistance Training

Resistance training benefits:

• Preservation of hippocampal volume
• Improved executive function
• Muscle mass correlation with cognitive performance

Combined Exercise Modalities

Evidence supports combined aerobic and resistance training for optimal cognitive benefits.

See: [Exercise Therapy in Neurodegeneration](/therapeutics/exercise-therapy-neurodegeneration), [Physical Exercise in Parkinson's Disease](/therapeutics/physical-exercise-parkinsons)

Cognitive Reserve and Mental Engagement

Cognitive reserve—the brain's resilience to pathological damage—is built through:

• Higher education and lifelong learning
• Complex occupational activities
• Cognitively stimulating leisure activities
• Social engagement and intellectual pursuits

• Protective effects even in the presence of significant amyloid pathology
• Neural compensation mechanisms in high-reserve individuals
• Interventions to build reserve in older adults

Sleep and Circadian Rhythm

Emerging evidence links sleep quality to AD risk:

• Glymphatic clearance of [amyloid-beta](/proteins/amyloid-beta) during sleep
• Association between sleep disorders and increased AD biomarkers
• Circadian rhythm disruption and tau pathology

Social Engagement and Mental Health

Social isolation is a major risk factor with 5% population attributable fraction:

• Loneliness associated with elevated cortisol and neuroinflammation
• Social engagement provides cognitive stimulation
• Depression treatment may reduce dementia risk

Implementation and Public Health

World-Wide FINGERS Network

The World-Wide FINGERS initiative has now expanded to 46+ countries[@worldfingers2024]:

• Adapting FINGER protocol to diverse populations
• Cultural adaptations for diet and lifestyle interventions
• Resource-efficient delivery models

Personalized Prevention

AAIC 2026 featured research on personalized prevention strategies:

• [APOE4](/genes/apoe) genotype-guided recommendations
• Polygenic risk scores for targeting interventions
• Biomarker-based risk stratification

Cross-References and Related Content

Key NeuroWiki Pages

• [Modifiable Risk Factors for Dementia](/mechanisms/modifiable-risk-factors)
• [FINGER Trial Prevention](/mechanisms/finger-trial)
• [SPRINT-MIND Blood Pressure Study](/mechanisms/sprint-mind-study)
• [Mediterranean Diet](/therapeutics/mediterranean-diet-neurodegeneration)
• [MIND Diet](/therapeutics/mediterranean-mind-diet-neurodegeneration)
• [Exercise Therapy](/therapeutics/exercise-therapy-neurodegeneration)
• [Cognitive Reserve](/mechanisms/cognitive-reserve)
• [APOE4 and Prevention](/therapeutics/apoe-genotype-guided-prevention)

Related AAIC 2026 Sessions

• [AAIC 2026: Prevention Trials](/events/aaic-2026/prevention-trials)
• [AAIC 2026: Early Detection](/events/aaic-2026/early-detection)
• [AAIC 2026: Fluid Biomarkers](/events/aaic-2026/fluid-biomarkers)
• [AAIC 2026: Neuroinflammation](/events/aaic-2026/neuroinflammation)

Clinical Recommendations

Based on AAIC 2026 findings:

Research Gaps and Future Directions

• Optimal intervention timing and duration
• Long-term sustainability of lifestyle changes
• Cost-effectiveness of population-level interventions
• Integration with anti-amyloid therapies

References